Decreased levels of serum Angiotensin-(1-7) in patients with pulmonary arterial hypertension due to congenital heart disease

International Journal of Cardiology

Volumn 176, Issue 3, 2014, Pages 1399-1401

  Dai, Hailong ^a,b   Gong, Yongfei ^a   Xiao, Zhicheng ^a,b   Guang, Xuefeng ^a   Yin, Xiaolong ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Angiotensin (1 7); Congenital heart disease; Pulmonary arterial hypertension

Indexed keywords

ANGIOTENSIN I; ANGIOTENSIN I (1-7); PEPTIDE FRAGMENT;

ADULT; BLOOD; COMPLICATION; CONGENITAL HEART MALFORMATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERTENSION, PULMONARY; LUNG WEDGE PRESSURE; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR REMODELING;

ADULT; ANGIOTENSIN I; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTENSION, PULMONARY; MALE; PEPTIDE FRAGMENTS; PULMONARY WEDGE PRESSURE; VASCULAR REMODELING;

EID: 84908251519     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.08.021     Document Type: Article

References (16)

1. G. Simonneau, M.A. Gatzoulis, and I. Adatia Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 62 25 Suppl. 2013 D34 D41
2. M. D'Alto, and G.P. Diller Pulmonary hypertension in adults with congenital heart disease and Eisenmenger syndrome: current advanced management strategies Heart 100 17 2014 1322 1328
3. A.J. Ferreira, V. Shenoy, and Y. Yamazato Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension Am J Respir Crit Care Med 179 11 2009 1048 1054
4. V. Shenoy, Y. Qi, M.J. Katovich, and M.K. Raizada ACE2, a promising therapeutic target for pulmonary hypertension Curr Opin Pharmacol 11 2 2011 150 155
5. V. Shenoy, A.J. Ferreira, and Y. Qi The ACE2/Ang-(1-7)/MAS axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension Am J Respir Crit Care Med 182 8 2010 1065 1072
6. L. Chen, J. Xiao, Y. Li, and H. Ma Ang-(1-7) might prevent the development of monocrotaline induced pulmonary arterial hypertension in rats Eur Rev Med Pharmacol Sci 15 1 2011 1 7
7. H.L. Dai, Y. Guo, X.F. Guang, Z.C. Xiao, M. Zhang, and X.L. Yin The changes of serum angiotensin-converting enzyme 2 in patients with pulmonary arterial hypertension due to congenital heart disease Cardiology 124 4 2013 208 212
8. H.L. Dai, Y. Guo, X.L. Yin, X.F. Guang, Y.B. Lu, and W.H. Zhang The changes of serum angiotensin-converting enzyme 2 activity in patients with pulmonary arterial hypertension due to congenital heart disease (in Chinese) Chin J Cardiovasc Res 11 7 2013 481 483
9. M.B. Taylor, and P.C. Laussen Fundamentals of management of acute postoperative pulmonary hypertension Pediatr Crit Care Med 11 2 Suppl. 2010 S27 S29
10. D.M. Smadja, P. Gaussem, and L. Mauge Circulating endothelial cells: a new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease Circulation 119 3 2009 374 381
11. G. Li, Y.L. Xu, and F. Ling Angiotensin-converting enzyme 2 activation protects against pulmonary arterial hypertension through improving early endothelial function and mediating cytokines levels Chin Med J 125 8 2012 1381 1388
12. Y. Yamazato, A.J. Ferreira, and K.H. Hong Prevention of pulmonary hypertension by angiotensin-converting enzyme 2 gene transfer Hypertension 54 2 2009 365 371
13. A. Kleinsasser, I. Pircher, and B. Treml Recombinant angiotensin-converting enzyme 2 suppresses pulmonary vasoconstriction in acute hypoxia Wilderness Environ Med 23 1 2012 24 30
14. G. Li, Y. Liu, and Y. Zhu ACE2 activation confers endothelial protection and attenuates neointimal lesions in prevention of severe pulmonary arterial hypertension in rats Lung 191 4 2013 327 336
15. B. Rondelet, F. Kerbaul, and R. Van Beneden Prevention of pulmonary vascular remodeling and of decreased BMPR-2 expression by losartan therapy in shunt-induced pulmonary hypertension Am J Physiol Heart Circ Physiol 289 6 2005 H2319 H2324
16. V. Shenoy, A. Gjymishka, and Y.P. Jarajapu Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models Am J Respir Crit Care Med 187 6 2013 648 657